IPAD-DB ID | C00171 |
Name | Baicalein |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 1 0 O 5 |
Molecular Weight | 270.24 g/mol |
IUPAC Name | 5, 6, 7-trihydroxy-2-phenylchromen-4-one |
InChI | InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7, 17-19H |
InChIKey | FXNFHKRTJBSTCS-UHFFFAOYSA-N |
Canonical SMILES | O=C1C=C(C2=CC=CC=C2)OC3=C1C(O)=C(C(O)=C3)O |
PubChem CID | 5281605 |
DrugBank Accession Number | DB16101 |
CAS Registry Number | 491-67-8 |
Molecular Weight(Computed by SwissADME) | 270.24 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 265.186 |
Density(Computed by ADMETlab 2.0) | 1.018 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.056 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.441 |
LogD(Computed by ADMETlab 2.0) | 2.248 |
logP(Computed by ADMETlab 2.0) | 3.215 |
TPSA(Computed by SwissADME) | 90.90 Ų |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 3 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.70 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |